News

The study sites include the Dana-Farber Cancer Institute, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center and will be conducted under the direction of Dr Matthew Kulke.

Barr, which markets its line of isotretinoin capsules under the tradename Claravis, will launch the new dosage strength immediately. The 30mg dose capsule will now join the 10mg,

The researchers were encouraged after a finding that a new chemotherapy drug works best in patients who have no expression of a specific genetic alteration. Research programs at

Chantix' approval was based on a comprehensive clinical trial program including four pivotal trials involving more than 2,000 cigarette smokers. Subjects on average had smoked about 21 cigarettes

By combining data from nine randomized clinical trials and evaluating clinical outcomes individually rather than in combination, the analysis was able to put a sharper focus on the

“Boston Scientific is excited to distribute this next-generation bulking agent,” said Eric Goorno, president of the urology and gynecology businesses at Boston Scientific. “This agent is designed to

Under terms of the agreement, Clinical Data’s PGxHealth division will provide Duke University’s Institute for Genome Sciences & Policy (IGSP) with non-exclusive access to its studies conducted to

In these experiments, mice were pre-treated with Senesco’s small interfering RNA (siRNA) against factor 5A-1 and then challenged with LPS, which causes a classic systemic inflammatory response. The

This group of companies includes the main producers of high quality artemisinin monotherapies. The companies will now focus their marketing efforts for malaria primarily on artemisinin combination therapies